Clinical Trials Directory

Trials / Unknown

UnknownNCT03023306

Preemptive Versus Preventive Antiemetic Treatment

Effectiveness of Preemptive Versus Preventive Antiemetic Treatment in Patients Undergoing Laparoscopic Cholecystectomy. A Randomized Double Blind Trial.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
115 (estimated)
Sponsor
University of Athens · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Patients aged between 20 and 70 years, ASA physical status I-III, and scheduled for laparoscopic cholecystectomy under general anaesthesia will be enrolled in the study. Patients will be randomized to the preemptive group to receive an antiemetic regime 1h before the start of surgery or to the intraoperative group to receive the same antiemetic drugs in the same doses intraoperatively, 30 min before the end of surgery. In the operating room standard monitoring and a standardized anesthetic technique will be implemented in all patients. Nausea, vomiting, retching and PONV (cumulative) will be recorded at PACU, at 4h, 8h and 24h postoperatively. Pain scores assessed by NRS (numerical rating scale) will be recorded at the same time points. Also, when patients received fluids and solid food by mouth will be recorded.

Conditions

Interventions

TypeNameDescription
OTHERAntiemetics perioperativelyPreemptive group ondansetron 4 mg will be administered 1h before surgery Intraoperative group Ondansetron 4 mg will be administered intraoperatively

Timeline

Start date
2018-11-01
Primary completion
2020-11-01
Completion
2020-11-01
First posted
2017-01-18
Last updated
2018-11-02

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT03023306. Inclusion in this directory is not an endorsement.